Literature DB >> 21455875

Multimodal endoscopic therapy for multifocal intraepithelial neoplasia and superficial esophageal squamous cell carcinoma - a case series.

V Becker1, M Bajbouj, R M Schmid, A Meining.   

Abstract

Local endoscopic procedures are increasingly used and accepted treatments for unifocal superficial esophageal squamous cell carcinoma (SESCC). In multifocal SESCC, esophagectomy with or without chemoradiotherapy is often regarded as standard therapy. However, a combination of local endoscopic resection and new techniques such as radiofrequency ablation may play an increasing role in the treatment of selected patients with multifocal SESCC. The aim of this series was to evaluate the feasibility of a multimodal endoscopic approach. We report a case series of six consecutive patients from a European tertiary center who underwent endoscopic treatment for multifocal SESCC. The treatment comprised endoscopic mucosal resection using the cap technique or endoscopic submucosal dissection, in combination with radiofrequency ablation. The main outcome measure was complete tumor eradication after therapy and during the follow-up period. Using such an approach, complete eradication of cancer was achieved in all patients during follow-up. No major adverse events occurred. In conclusion, in selected patients with multifocal or residual SESCC, local resection techniques in combination with radiofrequency ablation may be safe and potentially curative alternative treatments. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21455875     DOI: 10.1055/s-0030-1256310

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

Review 1.  Emerging indications of endoscopic radiofrequency ablation.

Authors:  Aymeric Becq; Marine Camus; Gabriel Rahmi; Vincent de Parades; Philippe Marteau; Xavier Dray
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial.

Authors:  Shun He; Jacques Bergman; Yueming Zhang; Bas Weusten; Liyan Xue; Xiumin Qin; Lizhou Dou; Yong Liu; David Fleischer; Ning Lu; Sanford M Dawsey; Gui-Qi Wang
Journal:  Endoscopy       Date:  2015-02-10       Impact factor: 10.093

3.  Prospective study of endoscopic focal cryoballoon ablation for esophageal squamous cell neoplasia in China.

Authors:  Yan Ke; Sanne N van Munster; Liyan Xue; Shun He; Yueming Zhang; Lizhou Dou; Yong Liu; Xudong Liu; Yumeng Liu; Wei Li; Ning Lv; Sanford M Dawsey; Bas L A M Weusten; Jacques J G H M Bergman; Guiqi Wang
Journal:  Gastrointest Endosc       Date:  2019-03-25       Impact factor: 9.427

4.  Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China.

Authors:  Xinying Yu; Sanne N van Munster; Yueming Zhang; Liyan Xue; David E Fleischer; Bas L A M Weusten; Ning Lu; Sanford S M Dawsey; Jacques J G H M Bergman; Guiqi Wang
Journal:  Gastrointest Endosc       Date:  2018-10-26       Impact factor: 9.427

5.  Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial.

Authors:  Marion-Anna Protano; Hong Xu; Guiqi Wang; Rebecca R Richards-Kortum; Sharmila Anandasabapathy; Alexandros D Polydorides; Sanford M Dawsey; Junsheng Cui; Liyan Xue; Fan Zhang; Timothy Quang; Mark C Pierce; Dongsuk Shin; Richard A Schwarz; Manoop S Bhutani; Michelle Lee; Neil Parikh; Chin Hur; Weiran Xu; Erin Moshier; James Godbold; Josephine Mitcham; Courtney Hudson
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

6.  A case of esophageal squamous cell intraepithelial neoplasia with positivity for type 16 human papillomavirus successfully treated with radiofrequency ablation.

Authors:  Alessandro Repici; Chiara Genco; Andrea Anderloni; Paola Spaggiari; Rossana Mineri; Rosanna Minieri; Alessandra Carlino; Manol Jovani; Vincenzo Villanacci; Prateek Sharma; Alberto Malesci
Journal:  J Gastrointest Oncol       Date:  2014-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.